Doseology Announces Launch of Corporate Communications Program

Core Viewpoint - Doseology Sciences Inc. is launching an Investor Communications Initiative aimed at enhancing disclosure practices, increasing investor engagement, and supporting long-term commercial and capital-markets strategies [1] Program Overview - The initiative includes a three-month engagement with Guerilla Capital and a one-year digital media communications agreement with Maynard Communications Ltd., both starting at management's discretion [2] - The program aims to align governance and disclosure practices with enhanced reporting standards, reflecting the company's commitment to transparent communication and responsible governance [3] Executive Commentary - The CEO emphasizes the importance of strong governance and disciplined communication for long-term success, highlighting the company's focus on transparent and timely disclosures [4] - The global consumer demand is shifting towards cleaner oral delivery formats, with functional and stimulant pouch products gaining traction [4] Market Trends - The global pouch market is projected to exceed USD 69.46 billion by 2032, with functional stimulant formats outpacing traditional energy categories, positioning Doseology's stimulant platform favorably within this growth trend [5] Guerilla Capital Engagement - Guerilla Capital will assist in broadening distribution of corporate updates, increasing visibility among retail and institutional investors, and supporting consistent disclosure standards [6] - The engagement is set for three months, with a compensation of CAD 30,000 [8] Maynard Communications Ltd. Engagement - A one-year agreement with Maynard Communications Ltd. will support digital advertising, content distribution, and enhanced retail visibility, with a compensation of CAD 200,000 [10][14]